David Bendahan

Biomarkers in facioscapulohumeral muscular dystrophy

PURPOSE OF REVIEW: Facioscapulohumeral muscular dystrophy is one of the most frequent myopathies. Its clinical presentation and genetic background are unique. FSHD needs reliable and measurable biomarkers to monitor the disease and assess the efficacy of therapeutic approaches. T...